|
Identification and therapy efficacy of Type 2 diabetes in Hispanic patients Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Identification and therapy efficacy of Type 2 diabetes in Hispanic patients conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Identification and therapy efficacy of Type 2 diabetes in Hispanic patients Clinical research trials and Identification and therapy efficacy of Type 2 diabetes in Hispanic patients health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Identification and therapy efficacy of Type 2 diabetes in Hispanic patients. Identification and therapy efficacy of Type 2 diabetes in Hispanic patients Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Identification and therapy efficacy of Type 2 diabetes in Hispanic patients clinical trial. Human subjects often get the best healthcare available for their Identification and therapy efficacy of Type 2 diabetes in Hispanic patients condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Identification and therapy efficacy of Type 2 diabetes in Hispanic patients  Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
For Condition: Diabetes Mellitus, Non-Insulin-Dependent
Status: No longer recruiting
Sponsor(s): National Center for Research Resources (NCRR) ,
Synopsis: The two major types of diabetes are type 1 and type 2 diabetes. Although most patients with type 2 diabetes are older than age 40, type 2 diabetes has been reported with increasing frequency among patients under the age of 20. This form of diabetes has been called type 2 diabetes of youth, abbreviated type 2Y. Little is known about the etiology of type 2Y; however, clinicians believe that it occurs most commonly in obese children of particular ethnic groups. A positive family history appears to be one major risk factor for developing type 2Y diabetes. The individual contribution of ethnicity, obesity, and genetics to type 2Y have yet to be elucidated. There is no consensus regarding treatment with type 2Y diabetes. Observation of our Hispanic patients in the Houston area reveals a large number with type 2Y. The major purpose of this study is to examine the genetic and environmental risk factors such as family history, ethnicity, and obesity in Hispanic children with type 2Y diabetes. SPECIFIC AIMS: 1) To examine the genetic and environmental risk factors and clinical signs associated with type 1 diabetes and type 2 diabetes of youth. 2) To compare the efficacy of the treatment modalities, insulin and oral agents, in type 2Y patients. METHODS: We will undertake a retrospective case study, to include a review of hypothesized risk factors in all the medical records of pediatric diabetes patients seen at University of Texas. We anticipate that approximately 200 patients with type 1 diabetes and 30 patients with type 2Y diabetes will be identified. A Sustacal challenge test will be done in patients with a suspected diagnosis of type 2Y in order to confirm the clinical diagnosis. Parents will be contacted by phone for a detailed pedigree intake. Type 1 and type 2Y patients will be compared for each of the studied features. A retrospective review of diabetes type 2 therapies used in type 2Y patients will be undertaken through further examination of the medical records in order to compare insulin treatment to oral agents. We will also test a subset of the patients for the gene identified in adult Hispanics with type 2 diabetes.
Details:
Eligibility:
Study Type: Observational, Defined Population
Minimum Age/Maximum Age: 10 Years/18 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Approximately 30 pediatric patients (ages 10-18) believed to have a diagnosis of type 2Y. Each subject must have been diagnosed for at least one year. Exclusion Criteria: - Patients over the age of 18 or under the age of 10 - Patients in whom intellectual functioning is impaired sufficiently to interfere with the understanding of the protocol.
Total Enrollment:
Location and Contact Information:
Additional Information:
Study ID Numbers: NCRR-M01RR02558-0129; M01RR02558
Study Start Date:
Record last reviewed: April 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004572
Other Diabetes Mellitus, Non-Insulin-Dependent Studies:
1. LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients with Diabetes.
2. Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
3. Obese Patients with Type 2 Diabetes
4. Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide
5. Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Related Studies:
Other Diabetes Mellitus, Non-Insulin-Dependent Clinical Trials
Other Clinical Trials
Other Clinical Trials
Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
|
|
|
|
|
|
|
|
